{
    "id": "correct_foundationPlace_00080_0",
    "rank": 6,
    "data": {
        "url": "https://www.linkedin.com/posts/c-path_givingtuesday-givingtuesday-cpath-activity-7133854282646241280-7Y4m",
        "read_more_link": "",
        "language": "en",
        "title": "Path) on LinkedIn: #givingtuesday #givingtuesday #cpath #collaboration #treatmentsandcures‚Ä¶",
        "top_image": "https://media.licdn.com/dms/image/D5622AQGrmI8bqBmqvw/feedshare-shrink_2048_1536/0/1700666659673?e=2147483647&v=beta&t=AfqhCyX6Q_0oxU_YdJ-D1yQ0re9pq-JnGvD9hmWITGk",
        "meta_img": "https://media.licdn.com/dms/image/D5622AQGrmI8bqBmqvw/feedshare-shrink_2048_1536/0/1700666659673?e=2147483647&v=beta&t=AfqhCyX6Q_0oxU_YdJ-D1yQ0re9pq-JnGvD9hmWITGk",
        "images": [
            "https://media.licdn.com/dms/image/D563DAQHcUnuaTgBHEw/image-scale_191_1128/0/1696306652876/c_path_cover?e=2147483647&v=beta&t=DZYAHvZm9WsCbfWLgg_vy2pdX1hucgfbJ98K54ZNa8c"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [
            "Critical Path Institute (C-Path)"
        ],
        "publish_date": "2023-11-24T16:30:01.571000+00:00",
        "summary": "",
        "meta_description": "Join our mission to lead collaborations that accelerate drug development and advance better treatments for people worldwide. \n\nC-Path will be participating‚Ä¶",
        "meta_lang": "en",
        "meta_favicon": "https://static.licdn.com/aero-v1/sc/h/al2o9zrvru7aqj8e1x2rzsrca",
        "meta_site_name": "",
        "canonical_link": "https://www.linkedin.com/posts/c-path_givingtuesday-givingtuesday-cpath-activity-7133854282646241280-7Y4m",
        "text": "Thank you to BizTucson Magazine and News 4 Tucson - KVOA for featuring C-Path in their \"The World is Watching Tucson\" feature and coverage. As we celebrate 20 years of impact and collaborations, C-Path remains a trusted and neutral partner, leading efforts to generate tools and solutions that de-risk and accelerate the drug development process. https://lnkd.in/gfNBVyT8 #CPath #BizTucson #KVOA #Tucson #Arizona #drugdevelopment #collaboration #partnership #datasharing\n\nC-Path‚Äôs Global Impact Conference is THE event that drug developers cannot afford to miss. Hosted this September 9-11, in Washington, D.C., we are thrilled to announce the first of our impressive lineup of speakers. These experts bring unparalleled insights across various diseases and therapeutic areas. With a roster featuring the best and brightest minds in drug development, and with the early-bird ü¶Ö registration rate expiring at 11:59 p.m. ET, Monday, July 22, why wait? üîó Register now and learn more: https://lnkd.in/g4TqwJVR. ‚ñ∂ Join FDA Center For Drug Evaluation and Research Director Patrizia Cavazzoni, M.D., for a focused session on how we can maximize the impact of CDER-led efforts for clinical trial modernization, while retaining scientific and clinical rigor. ‚ñ∂ Teresa Buracchio, MD, Director of the Office of Neuroscience, CDER, FDA, will be a panelist discussing biology-based disease staging approaches. ‚ñ∂ Naomi Knoble, PhD, Ph.D., Associate Director of Rare Disease Measurement Science in the Division of Clinical Outcome Assessment, Office of New Drugs, CDER, FDA, will join us for the fireside chat, ‚ÄúNavigating the patient-focused drug development roadmap: update on the RD-COA Resource.‚Äù We look forward to seeing you at #CGIC2024! Klaus Romero Kristen Swingle Kevin Perkins Collin Hovinga Diane Stephenson Joseph Hedrick #CPath #CGIC2024 #GlobalImpactConference #drugdevelopment #datasharing #collaboration #neurology #pediatrics #raredisease\n\nC-Path‚Äôs Huong Huynh Reagan and Smith Heavner, PhD, RN will be teaching as part of the University of Arizona Law, Health Law & Policy Program‚Äôs Regulatory Science Certificate courses. For those interested in the regulatory process in drug development, this program offers an excellent pathway. Applications for the fall semester are due by August 1. Register now: https://lnkd.in/gdvYkXZg #CPath #drugdevelopment #datasharing #regulatoryscience\n\nTOMORROW: The Influential Role of Patient Advocacy Groups in Registry Data Efforts Join us on Thursday, July 18, at 12 p.m. ET for an insightful webinar hosted by C-Path's Mitochondrial and Inherited Metabolic Diseases Task Force. Discover how patient advocacy groups are pivotal in driving registry data efforts for mitochondrial and inherited metabolic diseases, ensuring that patient experiences and outcomes are central to research and regulatory decision-making. Our presenters include: Sophia Zilber üå∫Board Member and Patient Registry Director, Cure Mito Foundation. Sophia brings over 20 years of experience in drug development and clinical data analysis, leading the global Leigh syndrome patient registry at the Cure Mito Foundation. Elizabeth Reynolds, Co-Founder and Executive Director, The Champ Foundation. Dr. Reynolds has spearheaded over $2 million in research grants for Single Large-scale mtDNA Deletion Syndromes and co-leads a multi-site Natural History Study and patient-registry. Amanda Klein, Executive Director, Critical Path for Lysosomal Diseases and the Alpha-1 Antitrypsin Deficiency Consortia at C-Path. Dr. Klein leads initiatives to accelerate drug development for mitochondrial and inherited metabolic diseases and is a key figure in the RDCA-DAP initiative. Don‚Äôt miss this opportunity to learn from experts about the crucial role of patient advocacy in advancing research and healthcare outcomes. üîó Register now to secure your spot: https://lnkd.in/eNExmF9R #CPath #PatientAdvocacy #MitochondrialDiseases #Webinar #HealthcareInnovation #DrugDevelopment #collaboration #datasharing\n\nJOIN US TOMORROW, July 18, for an in-depth look at the key considerations around the use of Bring Your Own Device (BYOD) approaches to electronic clinical outcome assessment data collection in clinical trials, developed and presented by members of the BYOD Project Team as part of the eCOA Consortium and PRO Consortium‚Äôs eCOA: Getting Better Together Initiative. Register now: https://lnkd.in/enx2u4Xb Karl McEvoy Kelly Dumais Chris Barden Heather Romero Scottie Kern eCOA members, include: ActiGraph Evinova Clario ICON plc Inspired Health IQVIA Kayentis Koneksa Mapi Research Trust Medable, Inc Medidata Solutions Medrio ObvioHealth Parexel Red Nucleus RWS Group Signant Health Suvoda TransPerfect Life Sciences uMotif WCG YPrime #CPath #eCOA #DHT #ACT #eCOAC #globalhealth #collaboration #drugdevelopment #datasharing #clinicaltrials\n\nJOIN US Thursday, July 18, for an in-depth look at the key considerations around the use of Bring Your Own Device (BYOD) approaches to electronic clinical outcome assessment data collection in clinical trials, developed and presented by members of the BYOD Project Team as part of the eCOA Consortium and PRO Consortium‚Äôs eCOA: Getting Better Together Initiative. Register now: https://lnkd.in/enx2u4Xb Karl McEvoy Kelly Dumais Chris Barden Heather Romero Scottie Kern eCOA members, include: ActiGraph Evinova Clario ICON plc Inspired Health IQVIA Kayentis Koneksa Mapi Research Trust Medable, Inc Medidata Solutions Medrio ObvioHealth Parexel Red Nucleus RWS Group Signant Health Suvoda TransPerfect Life Sciences uMotif WCG YPrime #CPath #eCOA #DHT #ACT #eCOAC #globalhealth #collaboration #drugdevelopment #datasharing #clinicaltrials\n\nUpcoming Webinar: The Influential Role of Patient Advocacy Groups in Registry Data Efforts Join us on Thursday, July 18, at 12 p.m. ET for an insightful webinar hosted by C-Path's Mitochondrial and Inherited Metabolic Diseases Task Force. Discover how patient advocacy groups are pivotal in driving registry data efforts for mitochondrial and inherited metabolic diseases, ensuring that patient experiences and outcomes are central to research and regulatory decision-making. Our presenters include: Sophia Zilber üå∫Board Member and Patient Registry Director, Cure Mito Foundation. Sophia brings over 20 years of experience in drug development and clinical data analysis, leading the global Leigh syndrome patient registry at the Cure Mito Foundation. Elizabeth Reynolds, Co-Founder and Executive Director, The Champ Foundation. Dr. Reynolds has spearheaded over $2 million in research grants for Single Large-scale mtDNA Deletion Syndromes and co-leads a multi-site Natural History Study and patient-registry. Amanda Klein, Executive Director, Critical Path for Lysosomal Diseases and the Alpha-1 Antitrypsin Deficiency Consortia at C-Path. Dr. Klein leads initiatives to accelerate drug development for mitochondrial and inherited metabolic diseases and is a key figure in the RDCA-DAP initiative. Don‚Äôt miss this opportunity to learn from experts about the crucial role of patient advocacy in advancing research and healthcare outcomes. üîó Register now to secure your spot: https://lnkd.in/eNExmF9R #CPath #PatientAdvocacy #MitochondrialDiseases #Webinar #HealthcareInnovation #DrugDevelopment #collaboration #datasharing"
    }
}